Re: Guidelines for the Book Building and the Determination of Offering Price to Public and Individual
Re: Guidelines for the Book Building and the Determination of Offering Price to Public and Individual (No. 2)
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 HEALTH
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH
Derivative Warrants | ALIHEA41C2304A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # A
Derivative Warrants | ALIHEA41C2304B | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # B
Derivative Warrants | ALIHEA28C2304A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # A
Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023
Derivative Warrants | ALIHEA28C2402A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2024
Derivative Warrants | ALIHEA28C2308A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN AUGUST 2023